GOP Battle on Stude...
Health Care: Drugs
Oncothyreon Inc. (ONTY: NASDAQ)
$1.78 -0.02 | -0.84%
06/18/13 - 04:00 PM ET
Growth Rates
| GROWTH RATES |
|---|
| REVENUE (Trailing 12 Quarters) |
| EARNINGS PER SHARE (Trailing 12 Quarters) |
| DIVIDENDS (Trailing 12 Quarters) |
Portfolios with ONTY
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- Contributor7 Cancer Drug Stocks to Kno...
- ContributorBreakout Stocks Of The Week...
Latest ONTY Headlines from TheStreet
- Commit To Purchase Oncothyreon At $1, Earn 11.5% Annualized 06.10.13 | 02:06 pm
- ASCO '13 Preview: Oncothyreon's Failed Lung Cancer Vaccine 05.15.13 | 06:05 pm
- 4 Biotech Stocks Under $10 Making Big Moves 04.09.13 | 02:04 pm
- 5 Stocks Under $10 Set to Soar 02.28.13 | 01:02 pm
- 3 Pharma Stocks Leaping on Unusual Volume 01.10.13 | 02:01 pm
- Biotech Stock Mailbag: Amicus, Amarin, Oncothyreon 12.21.12 | 07:12 am
- Stocks Slip as Pessimism Clouds Fiscal-Cliff Talks 12.19.12 | 02:12 pm
- Oncothyreon: A Failed Drug Autopsy Performed By A Short Seller 12.19.12 | 10:12 am
- Stock Futures Rise Ahead of Housing Data 12.19.12 | 07:12 am
- Merck KGaA, Oncothyreon Lung Cancer Drug Fails Late-Stage Study 12.19.12 | 06:12 am
Press Releases for ONTY
- Oncothyreon Announces $10 Million Registered Direct Offering To BVF Partners L.P. - PR Newswire 05.30.13 | 06:05 am
- Oncothyreon And Array Announce Collaboration To Develop And Commercialize Anti-HER2 Compound ARRY-380 - PR Newswire 05.30.13 | 06:05 am
- Oncothyreon To Present At Jefferies 2013 Global Healthcare Conference - PR Newswire 05.29.13 | 08:05 am
- Oncothyreon Announces Data For L-BLP25 And PX-866 To Be Presented At American Society Of Clinical Oncology Meeting - PR Newswire 05.16.13 | 06:05 am
- Oncothyreon Announces First Quarter 2013 Financial Results Conference Call - PR Newswire 05.02.13 | 08:05 am
- Oncothyreon To Present At Future Leaders In The Biotech Industry Conference - PR Newswire 03.29.13 | 08:03 am
- Oncothyreon Announces Full Year And Fourth Quarter 2012 Financial Results Conference Call - PR Newswire 03.07.13 | 08:03 am
- Oncothyreon To Present At Cowen And Company 33rd Annual Health Care Conference - PR Newswire 02.27.13 | 08:02 am
- Oncothyreon Announces That L-BLP25 (Stimuvax®) Did Not Meet Primary Endpoint Of Improvement In Overall Survival In Pivotal Phase 3 Trial In Patients With Non-Small Cell Lung Cancer - PR Newswire 12.19.12 | 06:12 am
- Oncothyreon Announces Presentations At Upcoming Investment Conferences In November 2012 - PR Newswire 11.07.12 | 08:11 am
Partner Headlines for ONTY
- UPDATE: Wedbush Upgrades Oncothyreon on Statistically Significant Overall Survival Benefit - Benzinga 05.17.13 | 01:05 pm
- Stock Watch Thursday, 20 December - Seeking Alpha 12.20.12 | 09:12 am
- Long term spread targets Oncothyreon - NASDAQ 08.30.12 | 04:08 pm
- Reassessing & Continuing To Monitor Portfolios For Success - Seeking Alpha 07.30.12 | 09:07 am
- Oncothyreon Announces Presentation of PX-866 Clinical Data at American Association of Clinical Oncology Annual Meeting - Benzinga 06.02.12 | 06:06 pm
- Must Know Equity Upgrades and Downgrades Wednesday - Wall St. Cheat Sheet 05.23.12 | 03:05 am
- Interesting Reaction To Oncothyreon's Share Offering - Seeking Alpha 03.30.12 | 08:03 am
- Cytori Is A Compelling Short Sale Opportunity - Seeking Alpha 03.19.12 | 09:03 am
- Oncothyreon And Lpath: Shares Collapsed, Primed For A Rebound? - Seeking Alpha 03.09.12 | 09:03 am
- Immunocellular Again Pushing To $2 - Seeking Alpha 02.15.12 | 09:02 am
